MENDEL SCOTT (Chief Financial Officer) reported 1 transaction at GENMARK DIAGNOSTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/1/2021ACC: 0001487371-21-000130
Officer· Chief Financial Officer
Since Aug 2018
-41.83K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
41.83K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−41.83K
Price / share
—
Trade value
—
% of position
7.6%
2/25/2021
549.03K→507.20K
Total
Net shares
−41.83K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2021 | F · Tax Withholding | −41.83K | — | — | 7.6% | 549.03K | 507.20K |
| Total | −41.83K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned115.49K
Total
115.49K indirect115.49K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 115.49K | Indirect |
| Total | 115.49K | 115.49K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported